Loading resource…

Mayo Clinic College of Medicine
Fungal infections are significant contributors to opportunistic infections in patients with HIV/AIDS, with common pathogens including Pneumocystis jirovecii, Cryptococcus neoformans, Histoplasma capsulatum, and Talaromyces marneffei. The incidence of these infections has decreased in high-income countries due to antiretroviral therapy, but remains a major issue in regions with high HIV prevalence. The document calls for affordable diagnostic tests and broader access to antifungal treatments to improve patient outcomes. It also discusses the epidemiology and treatment recommendations for specific fungal infections associated with HIV.
No account needed